Clinical Director, Outpatient ASP Director
Children's Mercy Hospital
Kansas City, MO, United States
Dr Rana El Feghaly is a pediatric infectious diseases physician, the infectious diseases clinical director, quality improvement director, and the director of the outpatient antibiotic stewardship program at Children’s Mercy Kansas City. She is an Associate Professor of Pediatrics at the University of Missouri-Kansas City School of Medicine. Dr El Feghaly received her medical degree from the Lebanese University in 2006. Following pediatrics residency at the State University of New York Upstate Medical University in Syracuse, NY, she completed her pediatric infectious diseases fellowship at Washington University School of Medicine in St Louis, MO. She joined the staff in the Division of Infectious Diseases at the University of Mississippi Medical Center in 2013, where she was the recipient of multiple teaching awards. She completed her Master of Science in Clinical Investigation in 2017. She joined Children’s Mercy Kansas City in 2017 where she’s been leading Children’s Mercy’s outpatient antibiotic stewardship efforts. Board certified in Pediatrics and Pediatric Infectious Diseases, she is an elected fellow of the Pediatric Infectious Diseases Society, the Infectious Diseases Society of America, and the Society of Pediatric Research. Dr. El Feghaly serves on the American Academy of Pediatrics Clinical Practice Guideline Subcommittee on urinary tract infections in children, the National Board of Medical Examiners Microbiology and Immunology Committee and Step 1 Interdisciplinary Committee, the Pediatric Infectious Diseases Society Nominations and Awards Committee, and Antimicrobial Stewardship Committee, chairing their education subcommittee, among multiple other national roles. She is leading SHARPS-OP, an international collaborative of over 59 pediatric institutions focused on improving antimicrobial stewardship in ambulatory settings. With her expertise in quality improvement, Dr El Feghaly’s research focuses on judicious use of antibiotics and diagnostic tests in the outpatient setting.
Disclosure(s): American Academy of Pediatrics: Honoraria (Ongoing); Association of professionals in infection control and epidemiology: Grant/Research Support (Ongoing); Merck and Company, Inc.: Grant/Research Support (Ongoing); National Board of Medical Examiners: Honoraria (Ongoing)
PW07 - Expanding Your Influence to Improve Antibiotic Use in Outpatient Settings
Wednesday, October 11, 2023
8:00 AM – 12:00 PM US ET
W77 - Outpatient Stewardship Metrics That Matter
Wednesday, October 11, 2023
8:55 AM – 9:15 AM US ET